Resona Asset Management Co. Ltd. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 258,743 shares of the healthcare conglomerate’s stock after selling 4,053 shares during the period. Resona Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $95,423,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in UNH. Rathbones Group PLC grew its position in UnitedHealth Group by 13.5% during the third quarter. Rathbones Group PLC now owns 35,077 shares of the healthcare conglomerate’s stock worth $12,876,000 after buying an additional 4,166 shares during the period. Sumitomo Life Insurance Co. lifted its position in shares of UnitedHealth Group by 45.7% during the 3rd quarter. Sumitomo Life Insurance Co. now owns 6,268 shares of the healthcare conglomerate’s stock valued at $2,301,000 after acquiring an additional 1,967 shares during the period. TIAA CREF Individual & Institutional Services LLC boosted its stake in shares of UnitedHealth Group by 4.9% during the 3rd quarter. TIAA CREF Individual & Institutional Services LLC now owns 27,665 shares of the healthcare conglomerate’s stock worth $10,155,000 after acquiring an additional 1,299 shares in the last quarter. FCA Corp TX boosted its stake in shares of UnitedHealth Group by 15.7% during the 3rd quarter. FCA Corp TX now owns 2,599 shares of the healthcare conglomerate’s stock worth $954,000 after acquiring an additional 352 shares in the last quarter. Finally, Whittier Trust Co. grew its holdings in shares of UnitedHealth Group by 32.1% in the 3rd quarter. Whittier Trust Co. now owns 96,038 shares of the healthcare conglomerate’s stock worth $36,427,000 after acquiring an additional 23,349 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on UNH. JPMorgan Chase & Co. lifted their price objective on UnitedHealth Group from $516.00 to $524.00 and gave the stock an “overweight” rating in a report on Friday, October 16th. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, October 14th. Sanford C. Bernstein dropped their price target on UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating for the company in a research report on Wednesday, October 14th. Piper Sandler lifted their price target on UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 14th. Finally, HC Wainwright set a $500.00 price objective on shares of UnitedHealth Group in a research report on Friday, October 16th. Twenty-one research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $465.70.
Check Out Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Stock Performance
UnitedHealth Group stock opened at $339.92 on Friday. The stock has a fifty day moving average of $388.64 and a two-hundred day moving average of $367.55. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The company has a market capitalization of $304.57 billion, a price-to-earnings ratio of 19.41, a PEG ratio of 1.49 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the prior year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.
More UnitedHealth Group News
Investors following UNH have been watching these news items:
- Positive Sentiment: TD Cowen raised its rating on UnitedHealth to Buy from Hold, increased its price target to $455 from $402, and named it a 2027 best idea. The firm sees a clearer path to stronger earnings as Medicare Advantage pricing becomes more rational, with mid-to-high-teens EPS growth possible. Article: UnitedHealth stock pops on Buy rating, price target raise from TD Cowen
- Negative Sentiment: A law firm announced an investigation into potential securities-law or business-practice violations by UnitedHealth or its senior management. The notice does not establish wrongdoing, but adds legal and reputational uncertainty. Article: UnitedHealth Group investigation notice
- Negative Sentiment: Investors remain concerned about proposed CMS Medicare Advantage audit and repayment rules, which could extend audit findings across contracts and reach back to earlier payment years. Those concerns have weighed on managed-care stocks and contributed to UnitedHealth’s recent decline. Article: UnitedHealth Shares Sink as New Federal Fraud Crackdown Sparks Healthcare Sell-Off
UnitedHealth Group Company Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
